FDA Approved: STIOLTO RESPIMAT — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for STIOLTO RESPIMAT (tiotropium bromide and olodaterol) from Boehringer Ingelheim Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Stiolto Respimat (tiotropium + olodaterol)

Snippet

SUPPL AP for STIOLTO RESPIMAT (TIOTROPIUM BROMIDE AND OLODATEROL)